The DOI matches its Crossref record; 247 of the 247 references it cites were found in a registry or an index.
Antibiotics and Bacterial Resistance—A Short Story of an Endless Arms Race
Open accessAbstract
Despite the undisputed development of medicine, antibiotics still serve as first-choice drugs for patients with infectious disorders. The widespread use of antibiotics results from a wide spectrum of their actions encompassing mechanisms responsible for: the inhibition of bacterial cell wall biosynthesis, the disruption of cell membrane integrity, the suppression of nucleic acids and/or proteins synthesis, as well as disturbances of metabolic processes. However, the widespread availability of antibiotics, accompanied by their overprescription, acts as a double-edged sword, since the overuse and/or misuse of antibiotics leads to a growing number of multidrug-resistant microbes. This, in turn, has recently emerged as a global public health challenge facing both clinicians and their patients. In addition to intrinsic resistance, bacteria can acquire resistance to particular antimicrobial agents through the transfer of genetic material conferring resistance. Amongst the most common bacterial resistance strategies are: drug target site changes, increased cell wall permeability to antibiotics, antibiotic inactivation, and efflux pumps. A better understanding of the interplay between the mechanisms of antibiotic actions and bacterial defense strategies against particular antimicrobial agents is crucial for developing new drugs or drug combinations. Herein, we provide a brief overview of the current nanomedicine-based strategies that aim to improve the efficacy of antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–247 of 247
MarR family proteins are important regulators of clinically relevant antibiotic resistance
Beggs, G. A., Brennan, R. G., & Arshad, M. (2019) · Protein Science · doi:10.1002/pro.3769 · Cited by 71
Li, Z., & Velkov, T. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-16373-0_4 · Cited by 68
Structural and functional insights into esterase-mediated macrolide resistance
Zieliński, M., Park, J., Sleno, B., & Berghuis, A. M. (2021) · Nature Communications · doi:10.1038/s41467-021-22016-3 · Cited by 68
Microbial Arsenal of Antiviral Defenses – Part I
Isaev, A. B., Musharova, O. S., & Severinov, K. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921030081 · Cited by 63
Reid, P. J., & Speyer, J. F. (1970) · Journal of Bacteriology · doi:10.1128/jb.104.1.376-389.1970 · Cited by 62
Efflux pumps and antimicrobial resistance: Paradoxical components in systems genomics
Kabra, R., Chauhan, N., Kumar, A., Ingale, P., & Singh, S. (2018) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2018.07.008 · Cited by 61
Mosaei, H., Molodtsov, V., Kepplinger, B., Harbottle, J., Moon, C., Jeeves, R. E., Ceccaroni, L., Shin, Y., Morton, S., Marrs, E. C. L., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.08.028 · Cited by 61
Prevalence and characterisation of quinolone resistance mechanisms in Salmonella spp.
Wasyl, D., Hoszowski, A., & Zając, M. (2014) · Veterinary Microbiology · doi:10.1016/j.vetmic.2014.01.040 · Cited by 58
Gagnon, S., Lévesque, S., Lefebvre, B., Bourgault, A., Labbé, A., & Roger, M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr379 · Cited by 56
Emerging resistance to aminoglycosides in lactic acid bacteria of food origin—an impending menace
Jaimee, G., & Halami, P. M. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7184-y · Cited by 56
The hydrophobic trap—the Achilles heel of RND efflux pumps
Aron, Z. D., & Opperman, T. J. (2017) · Research in Microbiology · doi:10.1016/j.resmic.2017.11.001 · Cited by 54
Molecular Basis of Rifampin Resistance inStreptococcus pneumoniae
Padayachee, T., & Klugman, K. P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2361 · Cited by 53
Microbial Arsenal of Antiviral Defenses. Part II
Isaev, A. B., Musharova, O. S., & Severinov, K. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921040064 · Cited by 53
Assembly and regulation of the chlorhexidine-specific efflux pump AceI
Bolla, J. R., Howes, A. C., Fiorentino, F., & Robinson, C. V. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003271117 · Cited by 51
Omadacycline: A Newly Approved Antibacterial from the Class of Tetracyclines
Durães, F., & Sousa, E. (2019) · Pharmaceuticals · doi:10.3390/ph12020063 · Cited by 50
Therapeutic compounds targeting Lipid II for antibacterial purposes
Malin, J. J., & de Leeuw, E. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s215070 · Cited by 50
Sarecycline interferes with tRNA accommodation and tethers mRNA to the 70S ribosome
Batool, Z., Lomakin, I. B., Polikanov, Y. S., & Bunick, C. G. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008671117 · Cited by 50
STUDIES ON THE ANTIBACTERIAL ACTION OF THE SULFONAMIDE DRUGS
Wood, W. B. (1942) · The Journal of Experimental Medicine · doi:10.1084/jem.75.4.369 · Cited by 49
Quinolone Resistance Mechanisms in Pneumococci
Eliopoulos, G. M. (2004) · Clinical Infectious Diseases · doi:10.1086/382709 · Cited by 49
WalK(S221P), a naturally occurring mutation, confers vancomycin resistance in VISA strain XN108
Peng, H., Hu, Q., Shang, W., Yuan, J., Zhang, X., Liu, H., Zheng, Y., Hu, Z., Yang, Y., Tan, L., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw518 · Cited by 47
Takada, H., & Yoshikawa, H. (2018) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2018.1444466 · Cited by 47
Hill, C. M., Krause, K. M., Lewis, S. R., Blais, J., Benton, B. M., Mammen, M., Humphrey, P. P. A., Kinana, A. D., & Janc, J. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01737-09 · Cited by 41
Raze, D., Dardenne, O., Hallut, S., Martínez‐Bueno, M., Coyette, J., & Ghuysen, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.534 · Cited by 40
STUDEMEISTER, A. E., & Quinn, J. P. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.8.1267 · Cited by 40
Edoo, Z., Arthur, M., & Hugonnet, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-09341-8 · Cited by 40
Low Trimethoprim Susceptibility of Anaerobic Bacteria Due to Insensitive Dihydrofolate Reductases
Then, R. L., & Angehrn, P. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.15.1.1 · Cited by 39
Structural basis for plazomicin antibiotic action and resistance
Golkar, T., Bassenden, A. V., Maiti, K., Arya, D. P., Schmeing, T. M., & Berghuis, A. M. (2021) · Communications Biology · doi:10.1038/s42003-021-02261-4 · Cited by 38
The Interplay between Daptomycin and the Immune System
Kelesidis, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00052 · Cited by 35
Chen, H., Wang, X., Yin, Y., Li, S., Zhang, Y., Wang, Q., & Wang, H. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1537-0 · Cited by 33
Huber, L., Giguère, S., Slovis, N. M., Álvarez‐Narváez, S., Hart, K. A., Greiter, M., Morris, E. R. A., & Cohen, N. D. (2020) · Environmental Microbiology · doi:10.1111/1462-2920.15020 · Cited by 31
Vancomycin mimicry: towards new supramolecular antibiotics
Flint, A. J., & Davis, A. P. (2022) · Organic & Biomolecular Chemistry · doi:10.1039/d2ob01381a · Cited by 28
Clinical use of lefamulin: A first‐in‐class semisynthetic pleuromutilin antibiotic
Covvey, J. R., & Guarascio, A. J. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13378 · Cited by 27
Resistance profiles and rpoB gene mutations of Mycobacterium tuberculosis isolates in Taiwan
Lin, Y., Tai, C.-H., Li, C.-R., Lin, C.-F., & Shi, Z. (2012) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2012.06.008 · Cited by 26
Leisner, J. J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00976 · Cited by 26
Infection caused by thymidine-requiring, trimethoprim-resistant bacteria
King, C. H., Shlaes, D. M., & Dul, M. J. (1983) · Journal of Clinical Microbiology · doi:10.1128/jcm.18.1.79-83.1983 · Cited by 23
Antibiotics Targeting the 30S Ribosomal Subunit: A Lesson from Nature to Find and Develop New Drugs
Giuliodori, A. M., Spurio, R., Milón, P., & Fabbretti, A. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666181025092546 · Cited by 22
Plazomicin against Multidrug-Resistant Bacteria: A Scoping Review
Alfieri, A., Franco, S. D., Donatiello, V., et al. (2022) · Life · doi:10.3390/life12121949 · Cited by 22
Quinolone Resistance Mechanisms in Pneumococci
Eliopoulos, G. M. (2004) · Clinical Infectious Diseases · doi:10.1086/382692 · Cited by 19
Split tasks of asymmetric nucleotide‐binding sites in the heterodimeric ABC exporter EfrCD
Hürlimann, L. M., Hohl, M., & Seeger, M. A. (2017) · FEBS Journal · doi:10.1111/febs.14065 · Cited by 18
Shih, Y.-H., Yu, C., Chang, K., Tseng, Y., Li, P.-J., Hsia, S., Chiu, K., & Shieh, T. (2022) · Pharmaceuticals · doi:10.3390/ph15040488 · Cited by 18
Stimuli-Responsive Nanoplatform-Assisted Photodynamic Therapy Against Bacterial Infections
Zhou, Y. L., Deng, W., Mo, M., Luo, D., Liu, H., Jiang, Y., Chen, W., & Xu, C. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.729300 · Cited by 17
Enzymatic Synthesis of Vancomycin-Modified DNA
Figazzolo, C., Bonhomme, F., Saidjalolov, S., Ethève‐Quelquejeu, M., & Hollenstein, M. (2022) · Molecules · doi:10.3390/molecules27248927 · Cited by 15
Le linézolide, premier antibiotique de la famille des oxazolidinones
Dutronc, H., Bocquentin, F., Galpérine, T., Lafarie, S., & Dupon, M. (2005) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2005.09.006 · Cited by 14
Krajewska, J., & Laudy, A. E. (2021) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.21307/pm-2021.60.4.20 · Cited by 8
Maget‐Dana, R., Lakey, J. H., & Ptak, M. (1988) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(88)90160-9 · Cited by 7
Biomolecular Recognition by Oligosaccharides and Glycopeptides: The NMR Point of View
Kövér, K. E., Szilágyi, L. S., Batta, G., Uhrı́n, D., & Jiménez‐Barbero, J. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00193-3 · Cited by 5
Metadata
- Authors
- Baran, A., Kwiatkowska, A., & Potocki, L.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-03-17
- Volume
- 24
- Issue
- 6
- Pages
- 5777
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4327968183
- Cited by
- 300
- References
- 247
- FWCI
- 21.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.